跳至主要内容
临床试验/JPRN-UMIN000005630
JPRN-UMIN000005630已完成未知

A clinical study of generic drug of bicalutamide on the efficacy and the safety in prostate cancer patients - A clinical study of generic bicalutamide in prostate cancer (GB-study)

Biwako health and welfare consortium0 个研究点目标入组 60 人开始时间: 2011年5月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
45years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. AST (GOT), ALT (GPT), ALP: > 2.5 times of institution standard value. 2. Serum creatinine: > 1.5 times of institution standard value. 3. WBC: < 3,000/mm3 4. Hemoglobin: < 10 g/dl 5. Platelet: < 75,000/mm3 6. Patient with critical illness (liver cirrhosis, liver failure, chronic kidney failure, heart failure, myocardial infarction within 3 months, uncontrolled hypertension, uncontrolled diabetes, serious pulmonary fibrosis, active interstitial pneumonia, immunodeficiency, active double cancer, etc) 7. Patients participating in any clinical researches or clinical trials. 8. Patients who were judged inappropriate for the clinical research by the investigator.

研究者

发起方
Biwako health and welfare consortium

相似试验